• Explore /
  • Poster
  • / A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.

A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.

Abstract Poster

Authors

Pashtoon Kasi

Pashtoon Murtaza Kasi

Mayo Clinic, Jacksonville, FL

Pashtoon Murtaza Kasi , Kellie Bodeker , Daniel James Berg , Chandrikha Chandrasekharan , Saima Sharif , Brian J. Smith , Sandy-Vollstedt@uiowA.edu Vollstedt , Heather Brown , Meghan Chandler , Joseph J. Cullen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02905578

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr TPS791)

Abstract #

TPS791

Poster Bd #

Q12

Abstract Disclosures

Similar Posters

First Author: Vincent Chung

First Author: Akihiro Ohba

First Author: Andrew Oar

First Author: Kazuo Watanabe